Simvastatin Does Not Have a Clinically Significant Pharmacokinetic Interaction With Fenofibrate in Humans-Reference-Cited by-同舟云学术

Simvastatin Does Not Have a Clinically Significant Pharmacokinetic Interaction With Fenofibrate in Humans

Published:2004-09 Issue:9 Volume:44 Page:1054-1062
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Bergman Arthur J.,Murphy Gail,Burke Joanne,Zhao Jamie J.,Valesky Robert,Liu Lida,Lasseter Kenneth C.,He Weili,Prueksaritanont Thomayant,Qiu Yue,Hartford Alan,Vega Jose M.,Paolini John F.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference29 articles.

1. Clinical pharmacokinetics and practical applications of simvastatin;Mauro;Clin Pharmacokinet,1993

2. Randomised trial of cholesterol lowering in 4444 patients with coronoary heart disease the Scandinavian Simvastatin Survival Study (4S);Scandinavian Simvastatin Survival Group;Lancet,1994

3. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study;Pedersen;Arch Intern Med,1996

4. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial;Collins;Lancet,2003

5. The Heart Protection Study: expanding the boundaries for high-risk coronary disease prevention;Farmer;Am J Cardiol,2003

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug–drug interactions between pemafibrate and statins on pharmacokinetics in healthy male volunteers: Open‐label, randomized, 6‐sequence, 3‐period crossover studies;Clinical and Translational Science;2024-07-30

2. Safety of Combined Statin and Fibrate Therapy: Risks of Liver Injury and Acute Kidney Injury in a Cohort Study from the Shizuoka Kokuho Database;Drugs - Real World Outcomes;2024-05-10

3. Simvastatin therapy in different subtypes of hypercholesterolemia – a physiologically based modelling approach;2023-02-02

4. Dyslipidemia in Chronic Kidney Disease;Evidence‐Based Nephrology;2022-11-18

5. Prevalence of and Factors Associated With the Prescription of Fibrates Among Patients Receiving Lipid-Lowering Drugs in Germany;Journal of Cardiovascular Pharmacology;2021-12